Thesis defense Marie-Rose Crombag anti-cancer drugs in the elderly05-09-2019
A priori dose reductions solely based on age are not advisable and may threaten optimal treatment outcome. This is what Marie-Rose Crombag concludes from her PhD research that she did in the NKI. On 5 September, she defended her thesis at Utrecht University. Her promotor was Jos Beijnen and het co-promotor was Alwin Huitema.